Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia

Cancer Chemother Pharmacol. 1982;7(2-3):161-7. doi: 10.1007/BF00254540.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Azacitidine / therapeutic use
  • Cell Division / drug effects*
  • Child
  • Child, Preschool
  • DNA, Neoplasm / metabolism
  • Drug Resistance
  • Etoposide / administration & dosage
  • Etoposide / therapeutic use*
  • Female
  • Flow Cytometry
  • Humans
  • Infant
  • Kinetics
  • Leukemia / drug therapy*
  • Leukemia / pathology
  • Male
  • Mitosis / drug effects
  • Podophyllotoxin / analogs & derivatives*

Substances

  • DNA, Neoplasm
  • Etoposide
  • Podophyllotoxin
  • Azacitidine